Lyons, France

Lydie Remolue


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lydie Remolue: Pioneering Innovations in Immunogenic Formulations

Introduction

Lydie Remolue is an innovative inventor based in Lyons, France. She has made significant contributions to the field of immunology and vaccine development. With her expertise, she has developed a patent that promises to enhance the effectiveness and safety of vaccines for various target animals.

Latest Patents

Lydie holds one patent titled “Immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants.” This invention provides novel immunological and vaccine formulations that utilize a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants are designed to be combined with a wide variety of immunogens, resulting in safe and effective vaccines for a diverse range of target animals. Immunogens may include inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids, or combinations thereof. The target animals for these innovative vaccines can range from humans to various species including murine, canines, felines, equines, porcines, ovines, caprines, and bovines.

Career Highlights

Throughout her career, Lydie has gained valuable experience by working with leading companies in the pharmaceutical sector. She has been associated with Sanofi Pasteur SA and Boehringer Ingelheim Animal Health USA Inc., where she has applied her knowledge to advance health solutions.

Collaborations

Lydie has collaborated with esteemed colleagues such as Guillaume Rigaut and Alexis Guy André Lucien Parisot. These partnerships have contributed to the innovative developments in her research, further establishing her as a key figure in the biomedical field.

Conclusion

Lydie Remolue's work in immunogenic formulations showcases her commitment to advancing public health through innovative vaccine development. Her patent reflects her expertise and dedication to improving vaccine safety and efficacy across multiple animal species, making her a noteworthy inventor in the realm of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…